Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27.9M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
12.3M
-
Shares change
-
+1.97M
-
Total reported value, excl. options
-
$376M
-
Value change
-
+$45.3M
-
Put/Call ratio
-
2.68
-
Number of buys
-
76
-
Number of sells
-
-65
-
Price
-
$30.62
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q1 2015
153 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q1 2015.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.3M shares
of 27.9M outstanding shares and own 44.02% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (1.55M shares), FMR LLC (1.36M shares), EAGLE ASSET MANAGEMENT INC (1.13M shares), Apex Capital Management (1.1M shares), STATE STREET CORP (779K shares), Invesco Ltd. (579K shares), BlackRock Fund Advisors (527K shares), MCCLAIN VALUE MANAGEMENT LLC (444K shares), Krensavage Asset Management, LLC (424K shares), and BlackRock Institutional Trust Company, N.A. (325K shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.